Literature DB >> 10912839

Bone density in Ehlers-Danlos syndrome.

L Carbone1, F A Tylavsky, A J Bush, W Koo, E Orwoll, S Cheng.   

Abstract

Ehlers-Danlos Syndrome (EDS) is the most common inherited disorder of connective tissue recognized. The objectives of the present study were to determine bone mineral density (BMD) and biochemical markers of bone metabolism in EDS. Twenty-three subjects with Type III EDS and 23 matched controls underwent BMD measurement by dual-Energy X-ray absorptiometry (DXA) of the lumbar spine and femoral neck. Health history questionnaires and biochemical markers of bone and connective tissue metabolism were also assessed. No significant differences in BMD at the lumbar spine or differences in biochemical markers of bone and connective tissue metabolism were found between EDS subjects and controls. EDS subjects had a significantly decreased BMD at the femoral neck compared with controls, but this difference disappeared after adjustment for body height, weight and physical activity levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10912839     DOI: 10.1007/s001980070104

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  11 in total

Review 1.  Bone Disease in Patients with Ehlers-Danlos Syndromes.

Authors:  Shuaa Basalom; Frank Rauch
Journal:  Curr Osteoporos Rep       Date:  2020-04       Impact factor: 5.096

2.  Skeletal fragility: an emerging complication of Ehlers-Danlos syndrome.

Authors:  Anna Maria Formenti; Mauro Doga; Stefano Frara; Marco Ritelli; Marina Colombi; Giuseppe Banfi; Andrea Giustina
Journal:  Endocrine       Date:  2018-12-15       Impact factor: 3.633

3.  Increased incident hip fractures in postmenopausal women with moderate to severe pelvic organ prolapse.

Authors:  Lubna Pal; Susan M Hailpern; Nanette F Santoro; Ruth Freeman; David Barad; Simon Kipersztok; Vanessa M Barnabei; Sylvia Wassertheil-Smoller
Journal:  Menopause       Date:  2011-09       Impact factor: 2.953

4.  Higher fracture prevalence and smaller bone size in patients with hEDS/HSD-a prospective cohort study.

Authors:  T Banica; M Coussens; C Verroken; P Calders; I De Wandele; F Malfait; H-G Zmierczak; S Goemaere; B Lapauw; L Rombaut
Journal:  Osteoporos Int       Date:  2019-12-24       Impact factor: 4.507

5.  Bone involvement in adult patients affected with Ehlers-Danlos syndrome.

Authors:  C Eller-Vainicher; A Bassotti; A Imeraj; E Cairoli; F M Ulivieri; F Cortini; M Dubini; B Marinelli; A Spada; I Chiodini
Journal:  Osteoporos Int       Date:  2016-04-15       Impact factor: 4.507

6.  Fracture incidence in Ehlers-Danlos syndrome - A population-based case-control study.

Authors:  Mary C Rolfes; David R Deyle; Katherine S King; Jennifer L Hand; Arne H Graff; Chris Derauf
Journal:  Child Abuse Negl       Date:  2019-03-08

Review 7.  Diseases affecting bone quality: beyond osteoporosis.

Authors:  Aasis Unnanuntana; Brian J Rebolledo; M Michael Khair; Edward F DiCarlo; Joseph M Lane
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

8.  Increased tobacco and alcohol use among women with joint hypermobility: a way to cope with anxiety?

Authors:  C Baeza-Velasco; A Stoebner-Delbarre; F Cousson-Gélie; G Pailhez; A Bulbena; F Baguet; M C Gély-Nargeot
Journal:  Rheumatol Int       Date:  2014-05-30       Impact factor: 2.631

Review 9.  Clinical Relevance of Joint Hypermobility and Its Impact on Musculoskeletal Pain and Bone Mass.

Authors:  Vito Guarnieri; Marco Castori
Journal:  Curr Osteoporos Rep       Date:  2018-08       Impact factor: 5.096

10.  Multiple fractures in infants who have Ehlers-Danlos/hypermobility syndrome and or vitamin D deficiency: A case series of 72 infants whose parents were accused of child abuse and neglect.

Authors:  M F Holick; A Hossein-Nezhad; F Tabatabaei
Journal:  Dermatoendocrinol       Date:  2017-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.